Annual Retained Earnings:
-$2.18B-$519.02M(-31.30%)Summary
- As of today, NTLA annual retained earnings is -$2.18 billion, with the most recent change of -$519.02 million (-31.30%) on December 31, 2024.
- During the last 3 years, NTLA annual retained earnings has fallen by -$1.47 billion (-209.73%).
- NTLA annual retained earnings is now -22726.29% below its all-time high of -$9.54 million, reached on December 31, 2014.
Performance
NTLA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$2.49B-$101.32M(-4.23%)Summary
- As of today, NTLA quarterly retained earnings is -$2.49 billion, with the most recent change of -$101.32 million (-4.23%) on September 30, 2025.
- Over the past year, NTLA quarterly retained earnings has dropped by -$445.81 million (-21.76%).
- NTLA quarterly retained earnings is now -11270.84% below its all-time high of -$21.94 million, reached on December 31, 2015.
Performance
NTLA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NTLA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -31.3% | -21.8% |
| 3Y3 Years | -209.7% | -134.5% |
| 5Y5 Years | -623.7% | -534.8% |
NTLA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -209.7% | at low | -134.5% | at low |
| 5Y | 5-Year | -623.7% | at low | -534.8% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low |
NTLA Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -$2.49B(-4.2%) |
| Jun 2025 | - | -$2.39B(-4.4%) |
| Mar 2025 | - | -$2.29B(-5.3%) |
| Dec 2024 | -$2.18B(-31.3%) | -$2.18B(-6.3%) |
| Sep 2024 | - | -$2.05B(-7.1%) |
| Jun 2024 | - | -$1.91B(-8.3%) |
| Mar 2024 | - | -$1.77B(-6.5%) |
| Dec 2023 | -$1.66B(-40.9%) | -$1.66B(-8.7%) |
| Sep 2023 | - | -$1.53B(-8.7%) |
| Jun 2023 | - | -$1.40B(-9.7%) |
| Mar 2023 | - | -$1.28B(-8.8%) |
| Dec 2022 | -$1.18B(-67.5%) | -$1.18B(-10.7%) |
| Sep 2022 | - | -$1.06B(-11.9%) |
| Jun 2022 | - | -$950.55M(-11.8%) |
| Mar 2022 | - | -$849.87M(-20.9%) |
| Dec 2021 | -$703.00M(-61.6%) | -$703.00M(-13.1%) |
| Sep 2021 | - | -$621.76M(-13.0%) |
| Jun 2021 | - | -$550.12M(-14.3%) |
| Mar 2021 | - | -$481.31M(-10.6%) |
| Dec 2020 | -$435.11M | -$435.11M(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -$392.92M(-7.6%) |
| Jun 2020 | - | -$365.08M(-9.7%) |
| Mar 2020 | - | -$332.68M(-10.6%) |
| Dec 2019 | -$300.88M(-49.7%) | -$300.88M(-10.4%) |
| Sep 2019 | - | -$272.60M(-9.5%) |
| Jun 2019 | - | -$248.97M(-11.5%) |
| Mar 2019 | - | -$223.28M(-11.1%) |
| Dec 2018 | -$201.03M(-66.0%) | -$201.03M(-10.5%) |
| Sep 2018 | - | -$181.96M(-14.3%) |
| Jun 2018 | - | -$159.26M(-16.2%) |
| Mar 2018 | - | -$137.04M(-13.1%) |
| Dec 2017 | -$121.11M(-126.1%) | -$121.11M(-24.7%) |
| Sep 2017 | - | -$97.15M(-18.8%) |
| Jun 2017 | - | -$81.79M(-23.6%) |
| Mar 2017 | - | -$66.20M(-23.6%) |
| Dec 2016 | -$53.57M(-144.2%) | -$53.57M(-24.6%) |
| Sep 2016 | - | -$43.01M(-21.1%) |
| Jun 2016 | - | -$35.52M(-24.1%) |
| Mar 2016 | - | -$28.63M(-30.5%) |
| Dec 2015 | -$21.94M(-130.0%) | -$21.94M |
| Dec 2014 | -$9.54M | - |
FAQ
- What is Intellia Therapeutics, Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual retained earnings year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly retained earnings year-on-year change?
What is Intellia Therapeutics, Inc. annual retained earnings?
The current annual retained earnings of NTLA is -$2.18B
What is the all-time high annual retained earnings for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual retained earnings is -$9.54M
What is Intellia Therapeutics, Inc. annual retained earnings year-on-year change?
Over the past year, NTLA annual retained earnings has changed by -$519.02M (-31.30%)
What is Intellia Therapeutics, Inc. quarterly retained earnings?
The current quarterly retained earnings of NTLA is -$2.49B
What is the all-time high quarterly retained earnings for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly retained earnings is -$21.94M
What is Intellia Therapeutics, Inc. quarterly retained earnings year-on-year change?
Over the past year, NTLA quarterly retained earnings has changed by -$445.81M (-21.76%)